Despite the promising preclinical data presented above, there are only a few clinical studies or case reports on the use of radiolabeled gastrin analogs in diagnostic imaging in MTC patients to support their efficacy. The gene discussed is GAST; the disease is medullary thyroid gland carcinoma.